Quarterly report · Q2
3645.TEDINET S100SMIQ
Period2023-06-01 → 2023-11-30
Filed2024-01-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.3bn | 2023-06-01 → 2023-11-30 | Cons. | Net sales |
| Revenue | ¥4.5bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.0bn | 2022-06-01 → 2022-11-30 | Cons. | Net sales |
| Operating income | ¥170m | 2023-06-01 → 2023-11-30 | Cons. | Operating income |
| Operating income | ¥178m | 2022-06-01 → 2022-11-30 | Cons. | Operating income |
| Ordinary income | ¥194m | 2023-06-01 → 2023-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥432m | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥205m | 2022-06-01 → 2022-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥192m | 2023-06-01 → 2023-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥207m | 2022-06-01 → 2022-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥116m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥116m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥116m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥126m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss |
| Net income | ¥130m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss |
| Total assets | ¥3.6bn | at 2023-11-30 | Cons. | Assets |
| Total assets | ¥3.5bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥3.4bn | at 2022-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2023-11-30 | Cons. | Liabilities |
| Total liabilities | ¥1.5bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.0bn | at 2023-11-30 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2022-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2023-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2023-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2023-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2022-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-05-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥131m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥429m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥59m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥14m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥62m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥32m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥14m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥18m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥906,000 | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥12.8 | 2023-06-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.39 | 2023-09-01 → 2023-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.97 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.09 | 2022-06-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.36 | 2022-09-01 → 2022-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 56.4% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.3% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.8% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-06-01 → 2023-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-06-01 → 2023-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-06-01 → 2023-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥562m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥562m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥315m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥70m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥70m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥7m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥1.7bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥1.7bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥68m |
| —segment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| —segment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| —segment total | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| —segment total | segment profit | 2023-06-01 → 2023-11-30 | ¥390m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2023-11-30 | ¥392m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-06-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-06-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-06-01 → 2022-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥499m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥499m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥2,000 |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥297m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥12,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥25m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥213,000 |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥51m |
| —segment total | revenue | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| —segment total | revenue external | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| —segment total | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥228,000 |
| —segment total | segment profit | 2022-06-01 → 2022-11-30 | ¥374m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥228,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2022-11-30 | ¥376m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 493
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)Mooreみらい監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)高砂 晋平 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)吉原 浩 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 1997979000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 2342045000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 4500846000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 205095000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 194049000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 431749000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 116213000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 115771000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 116181000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 132966000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 124987000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 114190000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 1947806000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 2029043000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 1929020000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 3426572000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 3568619000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 3467360000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 13.09 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 12.80 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 12.97 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.5575 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.5638 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.5529 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 59445000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | -130900000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 429134000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -32156000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -14267000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -62365000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -906000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | 14100000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -17902000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 1168714000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 1394325000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 1513349000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 7.36 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 10.39 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 10773000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 10773000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 10773000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 10773000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |